Hierarchical Micro- and Mesoporous Zeolitic Imidazolate Framework-8-Based Enzyme Hybrid for Combination Antimicrobial by Lysozyme and Lactoferrin
Inorganic Chemistry · 2024
DOI: 10.1021/acs.inorgchem.4c02082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Hao Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, P. R. China. Hauptthemen laut MEDLINE: Anti-Infective Agents, Metal-Organic Frameworks, Lactoferrin, Zeolites. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Fujian Agriculture and Forestry University.
Abstract (Originalsprache)
Pathogenic bacteria have consistently posed a formidable challenge to human health, creating the critical need for effective antibacterial solutions. In response, enzyme-metal-organic framework (MOF) composites have emerged as a promising class of antibacterial agents. This study focuses on the development of an enzyme-MOF composite based on HZIF-8, incorporating the advantages of simple synthesis, ZIF-8 antibacterial properties, lysozyme hydrolysis, and high biological safety. Through a one-pot method, core-shell nanoparticles (HZIF-8) were synthesized. This structure enables efficient immobilization of lysozyme and lactoferrin within the HZIF-8, resulting in the formation of the lysozyme-lactoferrin@HZIF-8 (LYZ-LF@HZIF-8) composite. Upon exposure to light irradiation, HZIF-8 itself possessed antibacterial properties. Lysozyme initiated the degradation of bacterial peptidoglycan and lactoferrin synergistically enhanced the antibacterial effect of lysozyme. All of the above ultimately contributed to comprehensive antibacterial activity. Antibacterial assessments demonstrated the efficacy of the LYZ-LF@HZIF-8 composite, effectively eradicating Staphylococcus aureus at a cell density of 1.5 × 106 CFU/mL with a low dosage of 200 μg/mL and completely inactivating Escherichia coli at 400 μg/mL with the same cell density. The enzyme-MOF composite exhibited significant and durable antibacterial efficacy, with no apparent cytotoxicity in vitro, thereby unveiling expansive prospects for applications in the medical and food industries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Applied Chemistry, College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, P. R. China.
ORCID-Profile: Zu-Jin Lin, Rong-Guang Lin
Förderung
- Fujian Agriculture and Forestry University
Zitieren
APA
Zheng, H., Sun, T., Zeng, Y., Zheng, M. Y., Zhang, F. Z., Wang, Y. L., Lin, Z. J., & Lin, R. G. (2024). Hierarchical Micro- and Mesoporous Zeolitic Imidazolate Framework-8-Based Enzyme Hybrid for Combination Antimicrobial by Lysozyme and Lactoferrin. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.4c02082
Vancouver
Zheng H, Sun T, Zeng Y, Zheng MY, Zhang FZ, Wang YL, et al. Hierarchical Micro- and Mesoporous Zeolitic Imidazolate Framework-8-Based Enzyme Hybrid for Combination Antimicrobial by Lysozyme and Lactoferrin. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.4c02082
BibTeX
@article{Zheng2024,
author = {Zheng, Hao and Sun, Tong and Zeng, Yan and Zheng, Mu-Yue and Zhang, Fang-Zhong and Wang, Yu-Lin and Lin, Zu-Jin and Lin, Rong-Guang},
title = {Hierarchical Micro- and Mesoporous Zeolitic Imidazolate Framework-8-Based Enzyme Hybrid for Combination Antimicrobial by Lysozyme and Lactoferrin},
journal = {Inorganic Chemistry},
year = {2024},
doi = {10.1021/acs.inorgchem.4c02082}
}
EUVIMED